IA
RDHL

IFP Advisors’s Redhill Biopharma RDHL Stock Holding History

IFP Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7
Closed -$2 – 4654
2024
Q3 		$2 Buy
+7
New +$69 ﹤0.01% 3296
2024
Q2 		– Hold
0
– – – 3223
2024
Q1 		– Hold
0
– – – 3109
2023
Q4 		– Hold
0
– – – 3020
2023
Q3 		– Hold
0
– – – 3282
2023
Q2 		– Sell
-12
Closed -$692 – 3428
2023
Q1 		$2.21K Buy
+12
New +$2.27K ﹤0.01% 2865
2022
Q4 		– Hold
0
– – – 4204
2022
Q3 		– Hold
0
– – – 4393
2022
Q2 		– Hold
0
– – – 4169
2022
Q1 		– Hold
0
– – – 4167
2021
Q4 		– Hold
0
– – – 3096
2021
Q3 		– Hold
0
– – – 3107
2021
Q2 		– Hold
0
– – – 2771
2021
Q1 		– Hold
0
– – – 2704
2020
Q4 		– Hold
0
– – – 2647
2020
Q3 		– Hold
0
– – – 2385
2020
Q2 		– Hold
0
– – – 2422
2020
Q1 		– Hold
0
– – – 2589
2019
Q4 		– Hold
0
– – – 2541
2019
Q3 		– Hold
0
– – – 2719

Other funds holding RDHL

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

IFP Advisors's RDHL Position: Q4 2024 in Review

IFP Advisors sold out of Redhill Biopharma (RDHL) in Q4 2024, closing a stake of 7 shares — an estimated $2 sold.

IFP Advisors first reported a position in RDHL in Q1 2023 and held it in 2 quarters. The position peaked at $2.21K in Q1 2023. 11 funds tracked by Wall St. Rank hold RDHL as of Q4 2024.

  • IFP Advisors reported no remaining Redhill Biopharma position as of Q4 2024 after selling out during the quarter.
  • IFP Advisors sold 7 Redhill Biopharma shares in Q4 2024, an estimated $2.
  • IFP Advisors first reported a position in Redhill Biopharma in Q1 2023 and held it in 2 quarters.
  • IFP Advisors's Redhill Biopharma position peaked at $2.21K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2024.

Based on IFP Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.